- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 2
Daily Deal Round Up: October 25, 2022
Gradient Ventures participated in a $40m series A round for The Coterie’s while Legal & General led MoneyHub’s $39.5m series B.
Oct 25, 2022Daily Deal Round Up: October 24, 2022
A range of corporates contributed to electric carmaker Aion’s $2.5bn series A round while Prosus took part in a $46m series E for farming services provider DeHaat.
Oct 24, 2022Daily Deal Round Up: October 21, 2022
AbbVie is acquiring Amgen-backed DJS Antibodies for $255m while Legend Holdings took part in a $56.6m series C round for VectorBuilder.
Oct 21, 2022Daily Deal Round Up: October 20, 2022
Alexandria Real Estate-backed Acrivon has filed to go public while H2 Green Steel increased its corporate-backed series B round to $255m.
Oct 20, 2022Daily Deal Round Up: October 19, 2022
Chengtun Mining Group took part in Hithium’s $278m series B round while HubSpot Ventures contributed to Jasper’s $125m series A.
Oct 19, 2022Daily Deal Round Up: October 18, 2022
Google was among the investors that helped lift Progcap’ series C round to $120m while Okta Ventures boosted Hycu’s $53m series B.
Oct 18, 2022Daily Deal Round Up: October 17, 2022
Tencent took part in a $400m round for Skydance Media while CrowdStrike helped Vanta hike its series B to $150m.
Oct 17, 2022Daily Deal Round Up: October 14, 2022
Rakuten-backed Base Food is set to list on TSE’s Growth Market in an IPO valuing it at $329m while Mitsui was part of a $400m round for Yellow Door Energy.
Oct 14, 2022Daily Deal Round Up: October 13, 2022
Thomas Reuters and Siemens participated in DataGrail’s $45m series C round while AyoConnect boosted its series B to $25m.
Oct 13, 2022Daily Deal Round Up: 12th October, 2022
Consumer credit provider FinAccel secured $140m from investors including GMO Payment Gateway while Amgen helped brain disease drug developer Neumora raise $112m.
Oct 12, 2022
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.